Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000643238 | SCV000237816 | likely benign | not provided | 2021-06-07 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26582918) |
Eurofins Ntd Llc |
RCV000327957 | SCV000343945 | likely benign | not specified | 2016-08-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086209 | SCV000764925 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000643238 | SCV001146546 | likely benign | not provided | 2018-11-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000643238 | SCV002049745 | uncertain significance | not provided | 2024-09-12 | criteria provided, single submitter | clinical testing | The TTN c.96016G>A; p.Val32006Met variant (rs191786700; ClinVar Variation ID: 203019) is rare in the general population (<0.2% allele frequency in the Genome Aggregation Database) and has not been reported in the medical literature in association with dilated cardiomyopathy (DCM) or other TTN-related disease. The clinical relevance of rare missense variants in this gene, which are identified on average once per individual sequenced in affected populations (Herman 2012), is not well understood. Yet, evidence suggests that the vast majority of such missense variants do not contribute to the clinical outcome of DCM (Begay 2015). Thus, the clinical significance of the p.Val32006Met variant cannot be determined with certainty. |
Ambry Genetics | RCV002362966 | SCV002662918 | likely benign | Cardiovascular phenotype | 2020-01-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000643238 | SCV003822353 | uncertain significance | not provided | 2020-06-26 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000327957 | SCV005423397 | likely benign | not specified | 2024-10-04 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.88312G>A (p.Val29438Met) results in a conservative amino acid change located in the A-band region of the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0002 in 1605752 control chromosomes in the gnomAD database (v4.1 dataset), including one homozygote. The variant was predominantly reported within the African or African-American subpopulation at a frequency of 0.0012, implying that it might be a benign polymorphism. To our knowledge, no occurrence of c.88312G>A in individuals affected with Limb-Girdle Muscular Dystrophy, Type 2J and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 203019). Based on the evidence outlined above, the variant was classified as likely benign. |
Clinical Genetics, |
RCV000643238 | SCV001924648 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000643238 | SCV001953223 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000643238 | SCV001978090 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000643238 | SCV002036700 | likely benign | not provided | no assertion criteria provided | clinical testing |